Case Studies show ReDS™ Lung Fluid Monitoring can reduce HF Readmissions up to 75%!

75% reductions in HF hospital readmissions at Cone Health and Geisinger!

A 70% reduction in HF hospital readmissions at Mount Sinai!

These were the results that doctors from these leading HF programs presented at HFSA in September.

The Results
Dr. Sanjay Doddamani of Geisinger Health called his ReDSTM data both “amazing” and “quite striking.” Although nearly half, 46%, of the 28 patients in the Geisinger study had been hospitalized in the 30 days prior to enrollment (some more than once), only 4 were re-hospitalized in the 30 days after ReDSTM was introduced to assess their lung fluid volume status and correlate their symptoms.

That’s a 75% reduction in HF-related hospital readmissions!

Dr. Daniel Bensimhon next detailed the results of Cone Health’s BEST Discharge Study, which was tasked with answering the question of whether patients were being discharged too early.  For the 100 patients in the study, when they were ready to go home, ReDSTM was brought in to measure their lung fluid content.  The study found that 33% of patients were being discharged with readings over 39%, and some readings surpassed 50%, much ‘wetter’ than normal readings between 20%-35%.  Separating this third of patients into a control group and a treatment group, the study found that those in the treatment group spent an extra 2 days in the hospital, lost 5-6 lbs. in water weight, but ultimately produced 75% fewer readmissions than those in the control group.

Dr. Sean Pinney, from Mount Sinai, presented similar results, explaining that by using ReDSTM to identify patients with congestion, his program could act earlier and prevent 30-day re-hospitalizations for his 28 patients.  Using readings from the ReDSTM vest guided his treatment, he explained, and during 2.5 months of point-of-care testing, Mount Sinai’s HF-related readmissions dropped 70%, from the 12% level to the 3.5% level.  AIso, information from ReDSTM was used to adjust the medications of 16 patients in the study.

Keeping Patients Safe, Dry, and at Home
By measuring lung fluid with ReDSTM, healthcare providers can guide treatment and keep patients safe, dry, and at home. As we saw at HFSA 2017, ReDSTM can keep patients well and out of the hospital, and help reduce HF hospital readmissions as much as 75%!  !  Watch soon for our next blog where we’ll discuss four reasons why both doctors and patients love ReDSTM.